These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15283844)

  • 41. A novel pathway of prostacyclin signaling-hanging out with nuclear receptors.
    Lim H; Dey SK
    Endocrinology; 2002 Sep; 143(9):3207-10. PubMed ID: 12193530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostanoids and inflammatory pain.
    Chen L; Yang G; Grosser T
    Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic Regulation in Adipocytes by Prostanoid Receptors.
    Inazumi T; Sugimoto Y
    Biol Pharm Bull; 2022; 45(8):992-997. PubMed ID: 35908909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
    Sharma S; Stolina M; Yang SC; Baratelli F; Lin JF; Atianzar K; Luo J; Zhu L; Lin Y; Huang M; Dohadwala M; Batra RK; Dubinett SM
    Clin Cancer Res; 2003 Mar; 9(3):961-8. PubMed ID: 12631593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology.
    Honda T; Tokura Y; Miyachi Y; Kabashima K
    Curr Drug Targets; 2010 Dec; 11(12):1605-13. PubMed ID: 20735353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse).
    Câmpean V; Theilig F; Paliege A; Breyer M; Bachmann S
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F19-32. PubMed ID: 12657565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds.
    Baber SR; Champion HC; Bivalacqua TJ; Hyman AL; Kadowitz PJ
    Circulation; 2003 Aug; 108(7):896-901. PubMed ID: 12900348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostanoid receptors: subtypes and signaling.
    Breyer RM; Bagdassarian CK; Myers SA; Breyer MD
    Annu Rev Pharmacol Toxicol; 2001; 41():661-90. PubMed ID: 11264472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention.
    Cathcart MC; O'Byrne KJ; Reynolds JV; O'Sullivan J; Pidgeon GP
    Biochim Biophys Acta; 2012 Jan; 1825(1):49-63. PubMed ID: 22015819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Inflammation-allergy and prostanoids. (1). Prostanoids in experimental inflammatory reaction].
    Ueno A; OhIshi S
    Nihon Yakurigaku Zasshi; 2001 Apr; 117(4):255-61. PubMed ID: 11338374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.
    Hata AN; Breyer RM
    Pharmacol Ther; 2004 Aug; 103(2):147-66. PubMed ID: 15369681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on the role of prostaglandins in allergic lung inflammation: separating friends from foes, harder than you might think.
    Moore ML; Peebles RS
    J Allergy Clin Immunol; 2006 May; 117(5):1036-9. PubMed ID: 16675329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positioning prostanoids of the D and J series in the immunopathogenic scheme.
    Herlong JL; Scott TR
    Immunol Lett; 2006 Feb; 102(2):121-31. PubMed ID: 16310861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
    Ermert L; Dierkes C; Ermert M
    Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostaglandin receptors are mediators of vascular function in endometrial pathologies.
    Jabbour HN; Sales KJ; Smith OP; Battersby S; Boddy SC
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):191-200. PubMed ID: 16701939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostanoid and isoprostanoid pathways in atherogenesis.
    Praticò D
    Atherosclerosis; 2008 Nov; 201(1):8-16. PubMed ID: 18514200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-Lipoxygenase Pathway, Dendritic Cells, and Adaptive Immunity.
    Hedi H; Norbert G
    J Biomed Biotechnol; 2004; 2004(2):99-105. PubMed ID: 15240920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of cyclooxygenase-2 and prostanoid receptors by human myometrium.
    Erkinheimo TL; Saukkonen K; Narko K; Jalkanen J; Ylikorkala O; Ristimäki A
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3468-75. PubMed ID: 10999850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostaglandin biosynthesis, transport, and signaling in corpus luteum: a basis for autoregulation of luteal function.
    Arosh JA; Banu SK; Chapdelaine P; Madore E; Sirois J; Fortier MA
    Endocrinology; 2004 May; 145(5):2551-60. PubMed ID: 14736737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostanoid receptors and the urogenital tract.
    Breyer MD; Hébert RL; Breyer RM
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1343-53. PubMed ID: 14758774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.